Literature DB >> 28303816

Occurrence of enteric parasitic infections among HIV-infected individuals and its relation to CD4 T-cell counts with a special emphasis on coccidian parasites at a tertiary care centre in South India.

Chinnambedu R Swathirajan1, Ramachandran Vignesh2, Ambrose Pradeep3, Sunil S Solomon4, Suniti Solomon1, Pachamuthu Balakrishnan1.   

Abstract

CONTEXT: Diarrhoea is one of the major complications occurring in over 90% of HIV-infected individuals in developing countries. Coccidian group of parasites, being opportunistic pathogens, have been implicated as the most common causative agents of diarrhoea among HIV-infected population. AIMS: The aim was to study the magnitude of parasitic diarrhoea with special context to coccidian parasitic infections in HIV-infected individuals and their association with the patient's immunological status measured by CD4 T-cell counts. SETTINGS AND
DESIGN: This investigation was performed between January 2002 and December 2014 at a tertiary HIV care centre in Chennai, South India.
MATERIALS AND METHODS: Stool samples were collected and microscopically observed for parasites using direct, formal-ether-concentrated wet mounts and modified acid-fast staining for coccidian parasites. CD4 T-cell counts were done by FACScount. STATISTICAL ANALYSIS USED: All statistical analyses were performed using GraphPad Prism software, version 5.0, andP < 0.05 was considered statistically significant.
RESULTS: Coccidian parasitic infection accounted for about 23.4% of parasitic infections, and of these, Cystoisospora belli was observed to be the most common cause of diarrhoea (88.8%), followed by Cryptosporidium spp. (9.9%) and Cyclospora spp. (1.3%). Trend analysis of coccidian aetiology during the study period revealed a significant rise in the positivity of C. belli and Cryptosporidium spp. (P = 0.001). Among the HIV patients with CD4+ T-cell counts <200 cells/μL, Cryptosporidium infection was most common (90%), followed by infection with C. belli(61.4%).
CONCLUSIONS: Coccidian parasites continue to be the most common aetiological agent of diarrhoea among patients with HIV. The increasing trend of positivity of both cystoisosporiasis and cryptosporidiosis over the study period and the high positivity of cryptosporidiosis in patients with lower CD4+ T-cell counts are issues of serious concern. The findings call for the need for the early diagnosis of coccidian parasites and appropriate intervention among HIV-infected patients.

Entities:  

Mesh:

Year:  2017        PMID: 28303816     DOI: 10.4103/ijmm.IJMM_16_164

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  4 in total

Review 1.  Global Burden of Cyclospora cayetanensis Infection and Associated Risk Factors in People Living with HIV and/or AIDS.

Authors:  Saba Ramezanzadeh; Apostolos Beloukas; Abdol Sattar Pagheh; Mohammad Taghi Rahimi; Seyed Abdollah Hosseini; Sonia M Rodrigues Oliveira; Maria de Lourdes Pereira; Ehsan Ahmadpour
Journal:  Viruses       Date:  2022-06-12       Impact factor: 5.818

2.  Profile of intestinal parasitic infections in human immunodeficiency virus/acquired immunodeficiency syndrome patients in Northeast India.

Authors:  Mohammed Ashraf Ali S Namaji; Sifa Harun Pathan; Anil Madhukar Balki
Journal:  Indian J Sex Transm Dis AIDS       Date:  2020-06-18

3.  Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis.

Authors:  Ehsan Ahmadpour; Hanie Safarpour; Lihua Xiao; Mehdi Zarean; Kareem Hatam-Nahavandi; Aleksandra Barac; Stephane Picot; Mohammad Taghi Rahimi; Salvatore Rubino; Mahmoud Mahami-Oskouei; Adel Spotin; Sanam Nami; Hossein Bannazadeh Baghi
Journal:  Parasite       Date:  2020-04-30       Impact factor: 3.000

Review 4.  Use-case scenarios for an anti-Cryptosporidium therapeutic.

Authors:  Paul G Ashigbie; Susan Shepherd; Kevin L Steiner; Beatrice Amadi; Natasha Aziz; Ujjini H Manjunatha; Jonathan M Spector; Thierry T Diagana; Paul Kelly
Journal:  PLoS Negl Trop Dis       Date:  2021-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.